• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雌激素替代疗法:适应证与并发症

Estrogen replacement therapy: indications and complications.

作者信息

Judd H L, Meldrum D R, Deftos L J, Henderson B E

出版信息

Ann Intern Med. 1983 Feb;98(2):195-205. doi: 10.7326/0003-4819-98-2-195.

DOI:10.7326/0003-4819-98-2-195
PMID:6824255
Abstract

Estrogen replacement therapy is one of the most controversial issues in the field of reproductive medicine. Indications for its use include hot flashes, vaginal atrophy, and risk of osteoporosis. Risk of heart disease may also be an indication but this use has not been firmly established. The role of estrogen replacement therapy in aging changes of skin needs clarification. Complications of therapy include endometrial cancer, breast cancer, hypertension, hyperlipidemia, and gallbladder disease. The last three complications presumably result from hepatic actions of estrogen replacement therapy.

摘要

雌激素替代疗法是生殖医学领域最具争议的问题之一。其使用指征包括潮热、阴道萎缩和骨质疏松风险。心脏病风险也可能是一个指征,但这种用途尚未得到确凿证实。雌激素替代疗法在皮肤衰老变化中的作用需要阐明。治疗的并发症包括子宫内膜癌、乳腺癌、高血压、高脂血症和胆囊疾病。后三种并发症可能是由雌激素替代疗法的肝脏作用引起的。

相似文献

1
Estrogen replacement therapy: indications and complications.雌激素替代疗法:适应证与并发症
Ann Intern Med. 1983 Feb;98(2):195-205. doi: 10.7326/0003-4819-98-2-195.
2
The menopause: benefits and risks of estrogen-progestogen replacement therapy.更年期:雌激素 - 孕激素替代疗法的益处与风险
Fertil Steril. 1982 Apr;37(4):457-74. doi: 10.1016/s0015-0282(16)46149-2.
3
Estrogen replacement therapy.雌激素替代疗法
Obstet Gynecol. 1981 Sep;58(3):267-75.
4
Effects of long-term estrogen replacement therapy. II. Neoplasia.长期雌激素替代疗法的影响。II. 肿瘤形成。
Am J Obstet Gynecol. 1979 Mar 1;133(5):537-47. doi: 10.1016/0002-9378(79)90289-8.
5
Estrogen replacement therapy--boon or bane? Current status of the controversy.雌激素替代疗法——福还是祸?争议现状
Postgrad Med. 1984 Mar;75(4):279-86. doi: 10.1080/00325481.1984.11697973.
6
Estrogen replacement in the menopause.更年期的雌激素替代疗法。
Obstet Gynecol Annu. 1979;8:369-91.
7
The menopause.更年期。
Invest Radiol. 1986 Apr;21(4):369-78. doi: 10.1097/00004424-198604000-00017.
8
Risks and benefits of long-term treatment with estrogens.雌激素长期治疗的风险与益处。
Schweiz Med Wochenschr. 1989 Dec 16;119(50):1811-20.
9
Selective estrogen modulators in menopause.绝经中的选择性雌激素调节剂
Minerva Ginecol. 2013 Dec;65(6):621-30.
10
DHEA, important source of sex steroids in men and even more in women.脱氢表雄酮(DHEA),男性性激素的重要来源,在女性中甚至更为重要。
Prog Brain Res. 2010;182:97-148. doi: 10.1016/S0079-6123(10)82004-7.

引用本文的文献

1
Efficacy and Safety of Shatavari Root Extract for the Management of Menopausal Symptoms: A Double-Blind, Multicenter, Randomized Controlled Trial.沙塔瓦里根提取物治疗更年期症状的疗效与安全性:一项双盲、多中心、随机对照试验。
Cureus. 2024 Apr 8;16(4):e57879. doi: 10.7759/cureus.57879. eCollection 2024 Apr.
2
Bipolar Disorder and Bone Mineral Density Z-Scores in Relation to Clinical Characteristics and Lithium Medication.双相情感障碍与骨矿物质密度Z评分与临床特征及锂盐治疗的关系
J Clin Med. 2022 Dec 1;11(23):7158. doi: 10.3390/jcm11237158.
3
Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways.
培门冬酶通过抑制 NFATc1、ERK 和 NF-κB 信号通路抑制 RANKL 诱导的破骨细胞生成。
Front Endocrinol (Lausanne). 2021 Sep 24;12:736863. doi: 10.3389/fendo.2021.736863. eCollection 2021.
4
Lipid Abnormalities in Patients With Cushing's Disease and Its Relationship With Impaired Glucose Metabolism.库欣病患者的脂质异常及其与糖代谢受损的关系。
Front Endocrinol (Lausanne). 2021 Feb 9;11:600323. doi: 10.3389/fendo.2020.600323. eCollection 2020.
5
Continual naringin treatment benefits the recovery of traumatic brain injury in rats through reducing oxidative and inflammatory alterations.持续柚皮苷治疗通过减轻氧化和炎症改变,有利于大鼠创伤性脑损伤的恢复。
Neurochem Res. 2014 Jul;39(7):1254-62. doi: 10.1007/s11064-014-1306-2. Epub 2014 Apr 13.
6
Parthenolide inhibits osteoclast differentiation and bone resorbing activity by down-regulation of NFATc1 induction and c-Fos stability, during RANKL-mediated osteoclastogenesis.在RANKL介导的破骨细胞生成过程中,小白菊内酯通过下调NFATc1的诱导和c-Fos的稳定性来抑制破骨细胞分化和骨吸收活性。
BMB Rep. 2014 Aug;47(8):451-6. doi: 10.5483/bmbrep.2014.47.8.206.
7
Post-menopausal Osteoporosis: Can it Be Prevented?绝经后骨质疏松症:可以预防吗?
Can Fam Physician. 1990 Mar;36:543-614.
8
Osteoporosis in primary biliary cirrhosis: a randomized trial of the efficacy and feasibility of estrogen/progestin.原发性胆汁性肝硬化中的骨质疏松症:雌激素/孕激素疗效与可行性的一项随机试验
Dig Dis Sci. 2006 Jun;51(6):1103-12. doi: 10.1007/s10620-006-8015-x.
9
Translating safety, efficacy and compliance into economic value for controlled release dosage forms.将控释剂型的安全性、有效性和依从性转化为经济价值。
Pharmacoeconomics. 1994 Jun;5(6):482-504. doi: 10.2165/00019053-199405060-00005.
10
Transdermal estroprogestins versus transdermal estrogen plus oral dihydrogesterone replacement in menopause.透皮雌激素孕激素与透皮雌激素加口服双氢孕酮在绝经后替代治疗中的比较
J Endocrinol Invest. 1996 May;19(5):268-72. doi: 10.1007/BF03347862.